Featured Stories

Other Pamplin Media Group sites

Vendors learn how

to court big companies

Small businesses wishing to get a foot in the sales door of large companies can find advice at the Portland Business Alliance's Business Development Day. Thursday's all-day event features presentations as well as representatives from a dozen companies such as Nike Inc., Intel Corp. and KinderCare Learning Centers Inc. The event runs from 8:30 a.m. to 5 p.m. at the Oregon Convention Center, 777 N.E. Martin Luther King Jr. Blvd.

The cost is $50. Attendees must belong to the Portland Metropolitan Small Business Alliance, part of the Portland Business Alliance; a free two-month trial membership is available. Participants can register online at www.portlandalliance.com.

FDA gives approval

to heart device

A microscopic-sized, drug-coated device that could greatly reduce the need for heart bypass surgery has been approved by the U.S. Food and Drug Administration.

The device, called a drug-eluting stent, was developed by a research team that included Portland cardiologist Dr. Andrew Carter, director of interventional cardiology research at Providence Heart Institute in Portland.

The stent's maker is Cordis Corp., a division of Johnson & Johnson, whose stock rose 68 percent to $57.48 when the FDA approval was announced Thursday.

Stents are tiny, wire-mesh tubes implanted into artery walls to keep them open. The device approved by the FDA last week is coated with a drug called sirolimus that is released into the artery to prevent the growth of scar tissue that could reclog the artery.

Ñ Tribune staff